FDA Inspection
Rottendorf Pharma GmbhRottendorf Pharma Gmbh – FDA Inspection, Feb 3, 2017
Record Details
This FDA Inspection record concerns Rottendorf Pharma Gmbh, with an inspection on February 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0e095728-bdef-4ae0-a54f-084c97066a7c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1005464
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.67(a)Cleaning / Sanitizing / Maintenance
- 21 CFR 211.22(d)Procedures not in writing, fully followed
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rottendorf Pharma Gmbh
5| Date | Classification | Office | Project area |
|---|---|---|---|
| March 14, 2024 | VAI | Drug Quality Assurance | |
| May 6, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 21, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 14, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 30, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Rottendorf Pharma Gmbh
- FDA Inspection 1303578 - 2024-03-14
- FDA Inspection 1247046 - 2021-05-06
- FDA Inspection 1083771 - 2019-02-21
- FDA Inspection 875352 - 2014-03-14
- FDA Inspection 779560 - 2012-03-30
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.